跳至主要内容
临床试验/NCT04833296
NCT04833296Unknown4 期

Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

Healthpoint Hospital2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2021年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
45
试验地点
2
主要终点
effective analgesic interscalene block

研究概览

简要总结

This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90% of patients (MEAC90)

详细描述

  • Before induction of general anesthesia, all patients will receive interscalene block using 15ml of ropivacaine which concentration will be based on the response of the previous patient.
  • Based on biased-coin design up-down sequential method: if patient has pain free recovery, a successful block, the next patient will be randomized to receive either the same ropivacaine concentration or a concentration 0.01% w/v less. However, if he has an unsuccessful block, the next patient will receive a concentration 0.01% w/v higher.
  • Patients with pain free recovery will be considered to have positive response.
  • Patients' responses will be analyzed to calculate the MEAC90.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients, who are scheduled for shoulder arthroscopy

排除标准

  • - <18 y,
  • ASA physical class greater >III
  • BMI >40 has any contraindication for medications or techniques used in the study

结局指标

主要结局

effective analgesic interscalene block

时间窗: in recovery unit (one hour after surgery)

postoperative pain (will be assessed using numerical rating scale. if ≥ 3, ineffective block will be considered and if \<3, an effective block will be considered

次要结局

未报告次要终点

研究者

发起方
Healthpoint Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmad Muhammad Taha

Consultant of anesthesia

Healthpoint Hospital

研究点 (2)

Loading locations...

相似试验